Analysis of adverse events and quality of life in high-grade serous ovarian cancer patients with Olaparib maintenance therapy: A single-center study in China

Olaparib showed good efficacy and tolerability in the maintenance treatment of patients with initial therapy or high-grade serous recurrent ovarian cancer patients. This study aimed to analyze adverse events (AEs) of patients taking Olaparib and the quality of life (QoL) with Olaparib in 1 center of...

Descripción completa

Detalles Bibliográficos
Autores principales: Jiang, Yi, Xu, Ting, Yuan, Lin, Zhang, Lin, Ruan, Xinjia, Wu, Shan, Meng, Huangyang, Cheng, Wenjun
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Lippincott Williams & Wilkins 2023
Materias:
5600
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10101289/
https://www.ncbi.nlm.nih.gov/pubmed/37058057
http://dx.doi.org/10.1097/MD.0000000000033434

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10101289/
https://www.ncbi.nlm.nih.gov/pubmed/37058057
http://dx.doi.org/10.1097/MD.0000000000033434

Ejemplares similares